Neurologists have made a plea to expand the availability of riluzole for patients with amyotrophic lateral sclerosis (ALS). PBS prescribing criteria for riluzole in do not reflect the latest evidence and may be denying the treatment to patient who would gain most benefit, according to Professor Matthew Kiernan and Dr Colin Mahoney of the Brain ...
Riluzole PBS restrictions deny treatment to ALS patients who may benefit most
By Michael Woodhead
21 Jan 2020